Goodbody Health Inc. announced that it is launching new genetic cancer tests to help customers gauge and understand their cancer and heart disease risk better in conjunction with Everything Genetic. These tests provide medically validated genetic testing for cancer and heart disease allowing customers to take control of their health and to detect potential problems at an early stage - when they are most treatable. These tests add to the existing portfolio to help customers to "Know More, Live Better".

The polygenic risk score tests will help to determine an individual's risk of developing the cancers tested for in the next 10 years, compared to someone in the general population. The full gene panels examine genes where it is known that a fault can increase risk of certain cancers and/or cardiac diseases. The utility of this test is particularly helpful where a family history of cancer or heart disease is known.

By combining both testing options, customers are provided with a thorough insight into their genetic predistortion to cancer and cardiac disease for improved health outcomes. 4 new tests are now offered through a simple saliva test taken with results delivered in approximately 4 weeks from receipt at the lab: Female Polygenic Risk Score Genetic Cancer Test This test gives a polygenic 10-year risk score and defines personal genetic predisposition for 3 common cancers by assessing the risk of developing breast cancer, colorectal cancer, and skin melanoma. Male Polygenic Risk Score Genetic Cancer Test This test gives a polygenic 10-year risk score and defines personal genetic predisposition for 3 common cancers by assessing the risk of developing prostate cancer, colorectal cancer, and skin melanoma.

Polygenic Risk Score Test + Full Gene Cancer Genetic Test The test provides all the above (depending on sex) but adds in a 30 gene cancer test that examines BRCA 1 and BRCA 2 genes, plus an additional 28 full genes which are specifically recognised as being linked to increased risk of various cancers if mutated. The test will look at the 30 full genes, identifying any mutations or changes that may make more likely to develop cancer. Polygenic Risk Score Test + Full Gene Cancer and Cardiac Disease Genetic Test The test provides all the above (Polygenic Risk Score - depending on sex + Full Gene Cancer Tests) and includes a cardiac test to examine 30 specific full genes that are specifically recognised as being linked to increased risk of inherited cardiac diseases if mutated.

The test will look at the 30 genes, identifying any mutations or changes that may make more likely to develop cardiac diseases that can lead to stroke, heart attack or sudden cardiac arrest at any age.